logo
  

Plus Therapeutics Inc. Q1 Loss Decreases, Beats Estimates

Plus Therapeutics Inc. (PSTV) reported Loss for first quarter that decreased from last year and beat the Street estimates.

The company's earnings totaled -$3.26 million, or -$0.75 per share. This compares with -$4.81 million, or -$2.07 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$1.09 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 229.4% to $1.68 million from $0.51 million last year.

Plus Therapeutics Inc. earnings at a glance (GAAP) :

-Earnings (Q1): -$3.26 Mln. vs. -$4.81 Mln. last year.
-EPS (Q1): -$0.75 vs. -$2.07 last year.
-Revenue (Q1): $1.68 Mln vs. $0.51 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Minutes of the latest Fed policy session dominated the economics scene this week. Find out what made policymakers give a “higher for longer” signal on interest rates. In Europe, the main news out this week was the inflation print from the U.K. Learn how the data was bad news for those hoping for an imminent rate cut from the Bank of England. Also, explore why New Zealand's central bank also hinted at a delay in its plans for interest rate reduction in future.

View More Videos
RELATED NEWS
Follow RTT